Introduction
Cardiovascular diseases (CVD) remain the leading cause of death in modern societies. Advancing age is the major risk factor for CVD and this is attributable primarily to pathophysiological changes in arteries [1] . These include structural remodeling featuring thickening of the intimal (inner) layer, increased expression of smooth muscle ␣ -actin (SM ␣ A), increased collagen synthesis/deposition, and inflammation linked to increased nuclear factor-B (NF B) and tumor necrosis factor-␣ (TNF-␣ ) signaling [1] [2] [3] [4] . The mechanisms involved are incompletely understood, but it has been assumed that these changes are caused by the actions of resident vascular smooth muscle cells that proliferate and migrate from the medial (middle) layer to the intimal layer [3] . Howev er, recent work indicates that in certain disease states such as pulmonary hypertension and fibrotic kidney disease, endothelial cells may transition to a 'mesenchymal' (smooth muscle-like) phenotype characterized by morphological changes, SM ␣ A expression, and increased secretion of collagen [5] [6] [7] . Inflammation has been hypothesized as a potential trigger for this transition and increases in transforming growth factor-␤ (TGF-␤ ) as a possible subsequent but early initiating factor [5, 7] . It is unknown if this type of phenotypic transi-tion can occur in a setting of cellular aging and, if so, whether inflammatory signaling or TGF-␤ are involved.
Here, we test the novel hypothesis that human endothelial cell aging results in an endothelial-mesenchymal transition (EnMT). To do so, we used a model of arterial endothelial cell aging in which human aortic endothelial cells are studied in early ('young') and late ('old') stages of replication [8, 9] . We also sought to gain insight into the possible roles of increased proinflammatory signaling and TGF-␤ in mediating EnMT in this model.
Methods
Human aortic endothelial cells were purchased from a commercial vendor (Lonza, Walkersville, Md., USA). These cells were characterized by positive staining for acetylated LDL and von Willebrand and negative staining for SM ␣ A according to the manufacturer's product sheet. In the initial culture (baseline), these cells did not express the smooth muscle marker, smooth muscle myosin heavy chain. All experiments were performed on primary cells from two different donors. Cells were obtained from a 65-year-old female and a 41-year-old male. Cells were grown in endothelial growth medium-2 (EGM-2) that was supplemented with growth factors, antibiotics, and 2% fetal bovine serum (EGM-2 SingleQuot; Lonza). Cells were passaged at ϳ 80% confluence and seeded at a density of 2,500-5,000 cells/cm 2 . All cells were studied at a confluence of ϳ 75-80%.
Population doubling levels (PDL) were calculated by taking the log 2 of the number of cells (living and dead) counted at a passage divided by the initial number of cells seeded on the plate [PDL = log 2 (number of cells at passage/number of initial cells)]. Cumulative PDL were calculated by summing the PDL from the current passage to the PDL of the previous passage (cumulative PDL = PDL of the current passage + PDL of the previous passage).
Whole cell preparation Western blotting was performed as previously described [10] . Briefly, early and late passage cells with or without 24-hour treatment with TGF-␤ (1-100 ng/ml; R&D Systems, Minneapolis, Minn., USA) or TNF-␣ (1-100 ng/ml; R&D Systems) were lysed in ice-cold RIPA buffer. Equal amounts of protein were loaded into a polyacrylamide gel and transferred to a nitrocellulose membrane. Primary antibodies for type I col- lagen (1: 2,000; Millipore, Billerica, Mass., USA), SM ␣ A (1: 10,000; Epitomics, Inc., Burlingame, Calif., USA), collagen IV (1: 500; Millipore), CD31, an endothelial cell marker (1: 500; Abcam, Cambridge, Mass., USA), and glyceraldehyde phosphate dehydrogenase (GAPDH) (1: 2,000; Cell Signaling Technology, Inc., Danvers, Mass., USA) were incubated overnight at 4 ° C. A secondary HRP-conjugated antibody (Jackson ImmunoResearch Laboratories, Inc., West Grove, Pa., USA) was incubated at room temperature for 1 h. Membranes were developed using ECL (Pierce/Thermo Scientific) and visualized using a digital acquisition system (ChemiDoc-It; UVP, Inc., Upland, Calif., USA). Collagen and SM ␣ A bands are expressed relative to GAPDH and normalized to the control group.
Senescence-associated ␤ -galactosidase staining was performed on early passage cells, early passage cells treated with TGF-␤ (10 ng/ml), early passage cells treated with TNF-␣ (10 ng/ ml), and late passage cells. Cells were grown on 4-well culture Data are presented as means 8 SEM. Statistical analysis was performed with PASW 18.0 software (PASW, Inc., Chicago, Ill., USA). A 2-tailed t test was used to compare the differences between early and late passage cells. A one-way ANOVA was used for TGF-␤ and TNF-␣ experiments with post hoc analyses where appropriate. p ! 0.05 was considered statistically significant. 
Results
Population doublings were greater in late compared with early passage human aortic endothelial cells (45.0 8 1.2 vs. 27.1 8 0.5, p ! 0.05). Late passage cells demonstrated increased spindle (smooth muscle-like) morphological changes ( fig. 1 a) , an 85% greater expression of SM ␣ A (1.85 8 0.36 vs. 1.00 8 0.05, p ! 0.05) ( fig. 1 b) , an ϳ 180% greater collagen I expression (2.78 8 0.43 vs. 1.00 8 0.31, p ! 0.05) ( fig. 1 c) , a 10-fold greater expression of the phosphorylated-to-total p65 subunit of NF B (10.17 8 2.20 vs. 1.00 8 0.26, p ! 0.05) ( fig. 1 d) , a 120% greater expression of TGF-␤ (2.21 8 0.16 vs. 1.00 8 0.35, p ! 0.05) ( fig. 1 e) , and a 67% reduction in MMP-2 expression To determine if inflammation can induce this EnMT, early passage cells were first incubated with 10 ng/ml of TNF-␣ for 24 h. Incubation with TNF-␣ increased expression of SM ␣ A (1.39 8 0.08 to 1.62 8 0.07, p ! 0.05) ( fig. 2 a) and collagen I (2.36 8 0.31 to 3.19 8 0.58, p ! 0.05) ( fig. 2 b) to levels not significantly different from those of late passage cells while inducing a late passage spindle phenotype ( fig. 2 c) . Twenty-four-hour dose-response experiments revealed increases in SM ␣ A with 1 and 10 ng/ml (both p ! 0.05), but not 100 ng/ml concentrations of TNF-␣ ( fig. 2 d) .
To determine if TGF-␤ can induce the EnMT, early passage cells were first incubated with 10 ng/ml of TGF-␤ for 24 h. In contrast to TNF-␣ , incubation with 10 ng/ml of TGF-␤ had no effect on SM ␣ A in young passage cells or on late passage cells ( fig. 3 a) . Further dose-response experiments revealed no effects of TGF-␤ on SM ␣ A at doses from 1 to 100 ng/ml ( fig. 3 b) .
Late passage cells demonstrated markedly increased staining for ␤ -galactosidase compared with early passage cells (p ! 0.05) ( fig. 4 ) . Incubation with TNF-␣ or with TGF-␤ (both 10 ng/ml) did not increase ␤ -galacosidase staining in early passage cells compared with early passage cells studied under control conditions ( fig. 4 ) .
Discussion
The present results show for the first time that EnMT can occur in a model of cellular aging. This is supported by the observation that several key features of EnMT including morphological changes and increased expression of SM ␣ A and collagen I were greater in late com- pared with early passage human aortic endothelial cells, with evidence for activation of the proinflammatory nuclear transcription factor NF B and the cytokine TGF-␤ despite reductions in MMP-2. We also observed a marked increase in ␤ -galactosidase staining, a marker of senescence, in late compared with early passage cells. Previous reports indicate that some vascular disease states are associated with EnMT [5] [6] [7] . The present findings extend this earlier work by showing that a model of primary human endothelial cell aging can also induce EnMT.
Our results also provide evidence for a role of inflammation in inducing EnMT with cellular aging. NF B activation and increased expression of TNF-␣ are observed in vascular endothelial cells from older healthy adult humans [11, 12] and in arteries of old rodents [2] and are related to vascular endothelial dysfunction [11] [12] [13] . Here, we show that this proinflammatory state can trigger EnMT in early passage human arterial endothelial cells similar to the phenotype observed in late passage cells. In contrast, the present results do not support an obvious role for TGF-␤ , which has been proposed as a possible initiating factor in EnMT associated with vascular disease [5] . Neither TNF-␣ nor TGF-␤ induced an increase in ␤ -galactosidase staining in early passage cells, suggesting that development of EnMT may precede senescence in this model. Intimal thickening featuring increased collagen deposition and inflammation is one of several key pathophysiological changes that occur in arteries with aging that increase the risk of CVD. As such, the present findings have important implications for the cellular and molecular mechanisms by which aging adversely effects arteries to increase their susceptibility to the development of clinical vascular diseases.
